Israeli authorises Moderna’s COVID-19 vaccine

Israel’s Ministry of Health (MOH) has given authorisation to import the Moderna’s COVID-19 vaccine in Israel.

“Today’s authorisation is a landmark moment in our company’s history and in the global fight against COVID-19,” said Stéphane Bancel, CEO of Moderna.

“This is the third regulatory authorisation for the COVID-19 Vaccine Moderna, and its first outside of North America.”

The MOH has secured 6 million doses of the COVID-19 Vaccine Moderna. Planned deliveries reflect today’s authorisation to supply the vaccine in Israel, and first deliveries are expected to begin shortly.

Israel is the third country for which Moderna has received authorisation for its COVID-19 vaccine, following the United States on December 18, 2020 and Canada on December 23, 2020.

Additional authorisations are currently under review in the European Union, Singapore, Switzerland and the United Kingdom.

The decision from the MOH is based on a rolling submission of data and is based on the totality of scientific evidence shared by the company, including a data analysis from the pivotal Phase 3 clinical study announced on November 30.

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site but journalism costs money and we rely on advertising and digital revenues to help to support them.

With the Covid-19 lockdown having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites with a small donation of even £1, your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

In the meantime may I wish you the very best.

- Advertisement -

Related news